Analysis of co-occurring and mutually exclusive amino acid changes and detection of convergent and divergent evolution events in SARS-CoV-2
- PMID: 35945925
- PMCID: PMC9352683
- DOI: 10.1016/j.csbj.2022.07.051
Analysis of co-occurring and mutually exclusive amino acid changes and detection of convergent and divergent evolution events in SARS-CoV-2
Abstract
The inflation of SARS-CoV-2 lineages with a high number of accumulated mutations (such as the recent case of Omicron) has risen concerns about the evolutionary capacity of this virus. Here, we propose a computational study to examine non-synonymous mutations gathered within genomes of SARS-CoV-2 from the beginning of the pandemic until February 2022. We provide both qualitative and quantitative descriptions of such corpus, focusing on statistically significant co-occurring and mutually exclusive mutations within single genomes. Then, we examine in depth the distributions of mutations over defined lineages and compare those of frequently co-occurring mutation pairs. Based on this comparison, we study mutations' convergence/divergence on the phylogenetic tree. As a result, we identify 1,818 co-occurring pairs of non-synonymous mutations showing at least one event of convergent evolution and 6,625 co-occurring pairs with at least one event of divergent evolution. Notable examples of both types are shown by means of a tree-based representation of lineages, visually capturing mutations' behaviors. Our method confirms several well-known cases; moreover, the provided evidence suggests that our workflow can explain aspects of the future mutational evolution of SARS-CoV-2.
Keywords: Co-occurring mutations; Convergent evolution; Divergent evolution; Mutually exclusive mutations; SARS-CoV-2; Statistical testing.
© 2022 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures












Similar articles
-
Perspectives: SARS-CoV-2 Spike Convergent Evolution as a Guide to Explore Adaptive Advantage.Front Cell Infect Microbiol. 2022 May 27;12:748948. doi: 10.3389/fcimb.2022.748948. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35711666 Free PMC article.
-
Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies.Virol J. 2024 May 7;21(1):105. doi: 10.1186/s12985-024-02378-y. Virol J. 2024. PMID: 38715113 Free PMC article.
-
Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational study.EBioMedicine. 2023 Nov;97:104843. doi: 10.1016/j.ebiom.2023.104843. Epub 2023 Oct 20. EBioMedicine. 2023. PMID: 37866115 Free PMC article.
-
SARS-CoV-2 evolution in the Omicron era.Nat Microbiol. 2023 Nov;8(11):1952-1959. doi: 10.1038/s41564-023-01504-w. Epub 2023 Oct 16. Nat Microbiol. 2023. PMID: 37845314 Review.
-
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics.Viruses. 2022 Jul 22;14(8):1603. doi: 10.3390/v14081603. Viruses. 2022. PMID: 35893668 Free PMC article. Review.
Cited by
-
Efficient discovery of frequently co-occurring mutations in a sequence database with matrix factorization.PLoS Comput Biol. 2025 Apr 24;21(4):e1012391. doi: 10.1371/journal.pcbi.1012391. eCollection 2025 Apr. PLoS Comput Biol. 2025. PMID: 40273414 Free PMC article.
-
Systematic analysis of SARS-CoV-2 Omicron subvariants' impact on B and T cell epitopes.PLoS One. 2024 Sep 19;19(9):e0307873. doi: 10.1371/journal.pone.0307873. eCollection 2024. PLoS One. 2024. PMID: 39298436 Free PMC article.
-
Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge.Int J Mol Sci. 2023 Jan 23;24(3):2264. doi: 10.3390/ijms24032264. Int J Mol Sci. 2023. PMID: 36768588 Free PMC article. Review.
References
-
- Al Khalaf R., Alfonsi T., Ceri S., Bernasconi A. CoV2K: a knowledge base of SARS-CoV-2 variant impacts. International Conference on Research Challenges in Information Science, Springer. 2021:274–282.
-
- Andreano E., Rappuoli R. SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies. Nat Med. 2021;27:759–761. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous